 | Up a level |
Fuchs, Michael; Jacob, Anne Sophie; Kaul, Helen; Kobe, Carsten; Kuhnert, Georg; Pabst, Thomas; Greil, Richard; Bröckelmann, Paul J; Topp, Max S; Just, Marianne; Hertenstein, Bernd; Soekler, Martin; Vogelhuber, Martin; Zijlstra, Josée M; Keller, Ulrich Bernd; Krause, Stefan W; Dührsen, Ulrich; Meissner, Julia; Viardot, Andreas; Eich, Hans-Theodor; ... (2024). Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma. Leukemia, 38(1), pp. 160-167. Springer Nature 10.1038/s41375-023-02064-y
Kreissl, Stefanie; Voltin, Conrad‐Amadeus; Kaul, Helen; Bühnen, Ina; Mettler, Jasmin; Pabst, Thomas; Eichenauer, Dennis A.; Fuchs, Michael; Diehl, Volker; Dietlein, Markus; Engert, Andreas; Borchmann, Peter; Kobe, Carsten (2022). Impact of bone marrow involvement on early positron emission tomography response and progression‐free survival in the HD18 trial for patients with advanced‐stage Hodgkin lymphoma. British journal of haematology, 197(1), e5-e8. Wiley-Blackwell 10.1111/bjh.17997
Kreissl, Stefanie; Goergen, Helen; Buehnen, Ina; Kobe, Carsten; Moccia, Alden; Greil, Richard; Eichenauer, Dennis A; Zijlstra, Josée M; Markova, Jana; Meissner, Julia; Feuring-Buske, Michaela; Soekler, Martin; Beck, Hans-Joachim; Willenbacher, Wolfgang; Ludwig, Wolf-Dieter; Pabst, Thomas; Topp, Max S; Hitz, Felicitas; Bentz, Martin; Keller, Ulrich Bernd; ... (2021). PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial. The Lancet. Haematology, 8(6), e398-e409. Elsevier 10.1016/S2352-3026(21)00101-0
Borchmann, Peter; Plütschow, Annette; Kobe, Carsten; Greil, Richard; Meissner, Julia; Topp, Max S; Ostermann, Helmut; Dierlamm, Judith; Mohm, Johannes; Thiemer, Julia; Sökler, Martin; Kerkhoff, Andrea; Ahlborn, Miriam; Halbsguth, Teresa V; Martin, Sonja; Keller, Ulrich; Balabanov, Stefan; Pabst, Thomas; Vogelhuber, Martin; Hüttmann, Andreas; ... (2021). PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial. The lancet oncology, 22(2), pp. 223-234. Elsevier 10.1016/S1470-2045(20)30601-X
Bröckelmann, Paul J; Müller, Horst; Guhl, Teresa; Behringer, Karolin; Fuchs, Michael; Moccia, Alden A; Rank, Andreas; Soekler, Martin; Vieler, Tom; Pabst, Thomas; Baues, Christian; von Tresckow, Bastian; Borchmann, Peter; Engert, Andreas (2021). Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy. Journal of clinical oncology, 39(2), pp. 107-115. American Society of Clinical Oncology 10.1200/JCO.20.00947
Kreissl, Stefanie; Müller, Horst; Goergen, Helen; Meissner, Julia; Topp, Max; Sökler, Martin; Markova, Jana; Bernhard, Jürg; Greil, Richard; von Tresckow, Bastian; Behringer, Karolin; Rüffer, Jens-Ulrich; Flechtner, Hans-Henning; Möstl, Michaela; Fuchs, Michael; Engert, Andreas; Diehl, Volker; Borchmann, Peter (2020). Health-Related Quality of Life in Patients With Hodgkin Lymphoma: A Longitudinal Analysis of the German Hodgkin Study Group. Journal of clinical oncology, 38(25), pp. 2839-2848. American Society of Clinical Oncology 10.1200/JCO.19.03160
Schmidt, Amand F; Holmes, Michael V; Preiss, David; Swerdlow, Daniel I; Denaxas, Spiros; Fatemifar, Ghazaleh; Faraway, Rupert; Finan, Chris; Valentine, Dennis; Fairhurst-Hunter, Zammy; Hartwig, Fernando Pires; Horta, Bernardo Lessa; Hypponen, Elina; Power, Christine; Moldovan, Max; van Iperen, Erik; Hovingh, Kees; Demuth, Ilja; Norman, Kristina; Steinhagen-Thiessen, Elisabeth; ... (2019). Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9. BMC cardiovascular disorders, 19(1), p. 240. BioMed Central 10.1186/s12872-019-1187-z
Mettler, Jasmin; Müller, Horst; Voltin, Conrad-Amadeus; Baues, Christian; Klaeser, Bernd; Moccia, Alden; Borchmann, Peter; Engert, Andreas; Kuhnert, Georg; Drzezga, Alexander; Dietlein, Markus; Kobe, Carsten (2019). Metabolic Tumor Volume for Response Prediction in Advanced-Stage Hodgkin Lymphoma. Journal of nuclear medicine, 60(2), pp. 207-211. Society of Nuclear Medicine 10.2967/jnumed.118.210047
Borchmann, Peter; Goergen, Helen; Kobe, Carsten; Lohri, Andreas; Greil, Richard; Eichenauer, Dennis A; Zijlstra, Josée M; Markova, Jana; Meissner, Julia; Feuring-Buske, Michaela; Hüttmann, Andreas; Dierlamm, Judith; Soekler, Martin; Beck, Hans-Joachim; Willenbacher, Wolfgang; Ludwig, Wolf-Dieter; Pabst Müller, Thomas Niklaus; Topp, Max S; Hitz, Felicitas; Bentz, Martin; ... (2018). PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group. Lancet, 390(10114), pp. 2790-2802. Elsevier 10.1016/S0140-6736(17)32134-7
von Tresckow, Bastian; Kreissl, Stefanie; Goergen, Helen; Bröckelmann, Paul J; Pabst Müller, Thomas Niklaus; Fridrik, Michael; Rummel, Mathias; Jung, Wolfram; Thiemer, Julia; Sasse, Stephanie; Bürkle, Carolin; Baues, Christian; Diehl, Volker; Engert, Andreas; Borchmann, Peter (2018). Intensive treatment strategies in advanced-stage Hodgkin's lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trials. The Lancet. Haematology, 5(10), e462-e473. Elsevier 10.1016/S2352-3026(18)30140-6
Skoetz, Nicole; Bohlius, Julia; Engert, Andreas; Monsef, Ina; Blank, Oliver; Vehreschild, Jörg-Janne (2015). Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy. Cochrane database of systematic reviews, 12(12), CD007107. WileyInterscience 10.1002/14651858.CD007107.pub3
Lohr, Frank; Georg, Dietmar; Cozzi, Luca; Eich, Hans Theodor; Weber, Damien Charles; Koeck, Julia; Knäusl, Barbara; Dieckmann, Karin; Abo-Madyan, Yasser; Fiandra, Christian; Mueller, Rolf-Peter; Engert, Andreas; Ricardi, Umberto (2014). Novel radiotherapy techniques for involved-field and involved-node treatment of mediastinal Hodgkin lymphoma: when should they be considered and which questions remain open? Strahlentherapie und Onkologie, 190(10), pp. 864-871. Springer-Medizin-Verlag 10.1007/s00066-014-0719-9
Skoetz, Nicole; Trelle, Sven; Rancea, Michaela; Haverkamp, Heinz; Diehl, Volker; Engert, Andreas; Borchmann, Peter (2013). Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis. Lancet oncology, 14(10), pp. 943-952. Oxford: Elsevier 10.1016/S1470-2045(13)70341-3
Behringer, Karolin; Mueller, Horst; Goergen, Helen; Thielen, Indra; Eibl, Angelika Diana; Stumpf, Volker; Wessels, Carsten; Wiehlpütz, Martin; Rosenbrock, Johannes; Halbsguth, Teresa; Reiners, Katrin S; Schober, Thomas; Renno, Jorg H; von Wolff, Michael; van der Ven, Katrin; Kuehr, Marietta; Fuchs, Michael; Diehl, Volker; Engert, Andreas and Borchmann, Peter (2013). Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials. Journal of clinical oncology, 31(2), pp. 231-9. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2012.44.3721
Tonia, Thomy; Mettler, Annette; Robert, Nadège; Schwarzer, Guido; Seidenfeld, Jerome; Weingart, Olaf; Hyde, Chris; Engert, Andreas; Bohlius, Julia (2012). Erythropoietin or darbepoetin for patients with cancer. Cochrane database of systematic reviews, 12(12), CD003407. Chichester: WileyInterscience 10.1002/14651858.CD003407.pub5
Naumann-Winter, Frauke; Greb, Alexander; Borchmann, Peter; Bohlius, Julia; Engert, Andreas; Schnell, Roland (2012). First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies. Cochrane database of systematic reviews, 10, CD004626. Chichester: WileyInterscience 10.1002/14651858.CD004626.pub3
Herbst, Christine; Rehan, Fareed Ahmed; Skoetz, Nicole; Bohlius, Julia; Brillant, Corinne; Schulz, Holger; Monsef, Ina; Specht, Lena; Engert, Andreas (2011). Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma. Cochrane database of systematic reviews(2), CD007110. Chichester: WileyInterscience 10.1002/14651858.CD007110.pub2
Hübel, Kai; Weingart, Olaf; Naumann, Frauke; Bohlius, Julia; Fresen, Maximilian M; Engert, Andreas; Wheatley, Keith (2011). Allogeneic stem cell transplant in adult patients with acute myelogenous leukemia: a systematic analysis of international guidelines and recommendations. Leukemia & lymphoma, 52(3), pp. 444-457. London: Informa Healthcare 10.3109/10428194.2010.546918
Herbst, Christine; Rehan, Fareed A; Brillant, Corinne; Bohlius, Julia; Skoetz, Nicole; Schulz, Holger; Monsef, Ina; Specht, Lena; Engert, Andreas (2010). Combined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin's lymphoma: a systematic review. Haematologica - the hematology journal, 95(3), pp. 494-500. Pavia: Ferrata-Storti Foundation 10.3324/haematol.2009.015644
Eich, Hans Theodor; Diehl, Volker; Görgen, Helen; Pabst, Thomas; Markova, Jana; Debus, Jürgen; Ho, Anthony; Dörken, Bernd; Rank, Andreas; Grosu, Anca-Ligia; Wiegel, Thomas; Karstens, Johann Hinrich; Greil, Richard; Willich, Normann; Schmidberger, Heinz; Döhner, Hartmut; Borchmann, Peter; Müller-Hermelink, Hans-Konrad; Müller, Rolf-Peter and Engert, Andreas (2010). Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial. Journal of clinical oncology, 28(27), pp. 4199-206. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2010.29.8018
Bohlius, Julia; Schmidlin, Kurt; Brillant, Corinne; Schwarzer, Guido; Trelle, Sven; Seidenfeld, Jerome; Zwahlen, Marcel; Clarke, Mike J; Weingart, Olaf; Kluge, Sabine; Piper, Margaret; Napoli, Maryann; Rades, Dirk; Steensma, David; Djulbegovic, Benjamin; Fey, Martin F; Ray-Coquard, Isabelle; Moebus, Volker; Thomas, Gillian; Untch, Michael; ... (2009). Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data. Cochrane database of systematic reviews, 2009(3), CD007303. Chichester: WileyInterscience 10.1002/14651858.CD007303.pub2
Herbst, Christine; Naumann, Frauke; Kruse, Eva-Brigitta; Monsef, Ina; Bohlius, Julia; Schulz, Holger; Engert, Andreas (2009). Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy. Cochrane database of systematic reviews(1), CD007107. Chichester: WileyInterscience 10.1002/14651858.CD007107.pub2
Bohlius, Julia; Schmidlin, Kurt; Brillant, Corinne; Schwarzer, Guido; Trelle, Sven; Seidenfeld, Jerome; Zwahlen, Marcel; Clarke, Michael; Weingart, Olaf; Kluge, Sabine; Piper, Margaret; Rades, Dirk; Steensma, David P; Djulbegovic, Benjamin; Fey, Martin F; Ray-Coquard, Isabelle; Machtay, Mitchell; Moebus, Volker; Thomas, Gillian; Untch, Michael; ... (2009). Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet, 373(9674), pp. 1532-42. London: Elsevier 10.1016/S0140-6736(09)60502-X
Bohlius, Julia; Engert, Andreas; Schwarzer, Guido (2008). Erythropoiesis-stimulating agents in the treatment of cancer-associated anemia. JAMA - the journal of the American Medical Association, 300(24), 2854-5; author reply 2855. Chicago, Ill.: American Medical Association
Kober, Thilo; Trelle, Sven; Engert, Andreas (2006). Reporting of randomized controlled trials in Hodgkin lymphoma in biomedical journals. Journal of the National Cancer Institute JNCI, 98(9), 620-5.. Cary, N.C.: Oxford University Press 10.1093/jnci/djj160
